7 Anti-Aging IV Drips Ranked: NAD+, Glutathione, NMN and What Each One Actually Does

The anti-ageing IV therapy market in India has grown rapidly — and with that growth has come considerable noise.

Walk into any wellness conversation in Delhi in 2026 and you will hear the names: NAD+, glutathione, NMN, Myers' Cocktail, vitamin C. They are discussed with varying levels of accuracy, frequently overpromised, occasionally dismissed, and rarely ranked against each other with genuine clinical transparency.

That is exactly what this article does.

At L&B Clinics, we approach anti-ageing IV therapy the same way we approach all clinical work — through the evidence. Not through marketing language, not through celebrity endorsement, and not through the enthusiasm of wellness culture that has outpaced the science it claims to represent.

Below are seven anti-ageing IV drips ranked by the strength of their mechanistic evidence, the quality of clinical data supporting their use, and their specific relevance to the physiological realities of ageing in India. Each ranking reflects what the peer-reviewed literature actually says — with references to support every claim.

Ranked 1: NAD+ IV Therapy — The Most Mechanistically Significant Anti-Ageing Intervention Available

If there is one molecule that sits at the intersection of the most important hallmarks of ageing, it is nicotinamide adenine dinucleotide — NAD+.

NAD+ is a coenzyme present in every cell of the human body, functioning as the essential substrate for mitochondrial energy production, DNA repair, and the activation of sirtuins — the family of proteins most directly associated with longevity regulation in the biological literature. It is also the substrate for PARP enzymes, which are responsible for detecting and repairing DNA strand breaks, and CD38, which regulates cellular calcium signalling and immune function (Verdin, 2015).

The problem — and it is a significant one — is that NAD+ levels fall by approximately 50 percent between the ages of 40 and 60 in humans. This decline is now recognised across multiple landmark studies as a primary driver of mitochondrial dysfunction, impaired DNA repair, sirtuin silencing, and the systemic metabolic deterioration that defines biological ageing (López-Otín et al., 2013).

Restoring NAD+ levels has been demonstrated to reverse measurable aspects of mitochondrial dysfunction, improve muscle insulin sensitivity, enhance cognitive function, and reduce systemic inflammation in clinical populations. Research published in Science by Yoshino et al. (2021) confirmed that NAD+ restoration in prediabetic women improved muscle insulin sensitivity — a core metabolic ageing marker — within ten weeks of supplementation.

The reason IV delivery is clinically superior for NAD+ is pharmacokinetic. Oral NAD+ precursors — nicotinamide riboside (NR) and NMN — require enzymatic conversion before they can raise intracellular NAD+ levels, and conversion efficiency varies significantly between individuals. IV NAD+ bypasses this conversion entirely, delivering the coenzyme directly into circulation at concentrations that produce rapid, measurable cellular effects (Yoshino et al., 2021).

At L&B Clinics, NAD+ IV therapy is administered over 2 to 4 hours per session in a monitored clinical environment. It ranks first not because it is the most fashionable anti-ageing therapy — but because its mechanism of action directly addresses more hallmarks of ageing simultaneously than any other single intervention currently available in IV form.

Ranked 2: High-Dose Vitamin C IV Therapy — Collagen, Epigenetics, and Immune Longevity

High-dose intravenous vitamin C holds the second position in this ranking because its evidence base is simultaneously among the broadest and most mechanistically precise of any longevity IV intervention.

Vitamin C operates across three distinct longevity-relevant pathways simultaneously.

First, it is the rate-limiting cofactor for collagen biosynthesis — specifically for the hydroxylation of proline and lysine residues that allow the collagen triple helix to form correctly. Without adequate vitamin C, collagen synthesis slows, existing collagen degrades faster, and the structural integrity of skin, blood vessels, joints, and connective tissue throughout the body deteriorates at an accelerated rate (Pullar, Carr and Vissers, 2017).

Second — and this is the dimension that positions vitamin C firmly in the longevity medicine conversation — it is an essential cofactor for the TET family of dioxygenase enzymes responsible for DNA demethylation. TET enzymes are the molecular machinery that maintains appropriate epigenetic programming — preventing the age-related drift in gene expression patterns that constitutes one of the primary hallmarks of ageing. Cimmino et al. (2018) demonstrated that TET enzyme activity is directly dependent on vitamin C availability, establishing a mechanistic link between vitamin C status and epigenetic ageing that fundamentally repositions this nutrient beyond its antioxidant role.

Third, IV vitamin C achieves plasma concentrations — up to 70 times higher than the oral ceiling — sufficient to activate immune surveillance mechanisms, support natural killer cell activity, and reduce systemic inflammatory markers that drive immunological ageing (Padayatty et al., 2004).

In India's high-UV, high-pollution environment, where vitamin C is continuously depleted by environmental oxidative load, IV delivery is the only reliable route to achieving the concentrations that these mechanisms require.

Ranked 3: Glutathione IV Therapy — The Master Antioxidant of Cellular Ageing

Glutathione earns its third-place ranking through a combination of mechanistic breadth, strong clinical evidence, and particular relevance to the Indian environmental context.

As the body's primary intracellular antioxidant, glutathione operates at the centre of cellular redox balance — neutralising free radicals, regenerating vitamins C and E after their antioxidant cycles, supporting mitochondrial integrity, and driving the liver's phase II detoxification pathways. Its decline with age — by up to 40 percent between young adulthood and the sixth decade — is directly associated with the accumulation of oxidative damage that accelerates virtually every hallmark of ageing (Pizzorno, 2014).

In Delhi and other major Indian cities, where air pollution generates continuous systemic free radical burden, glutathione depletion occurs at a rate significantly higher than in cleaner environments. This makes IV glutathione restoration not simply a general anti-ageing intervention but a specific environmental medicine response to the oxidative reality of urban Indian life.

The skin brightening effects of glutathione — driven by its inhibition of tyrosinase and consequent reduction in eumelanin synthesis — are well documented and represent a visible clinical marker of the deeper antioxidant restoration it produces systemically (Weschawalit et al., 2017). But framing glutathione exclusively as a skin treatment, as much of the Indian wellness market does, dramatically undersells its systemic longevity significance.

At L&B Clinics, glutathione is always co-administered with vitamin C — a clinically important combination that prevents glutathione oxidation in circulation and amplifies its tissue-level bioavailability. This pairing is not cosmetic preference; it is biochemical necessity.

Ranked 4: NMN (Nicotinamide Mononucleotide) IV Therapy — The NAD+ Precursor With Its Own Evidence Base

NMN occupies a distinct and important position in anti-ageing IV therapy — not as an alternative to NAD+, but as a complementary intervention with a growing and increasingly robust clinical evidence base.

NMN is the immediate biosynthetic precursor to NAD+. Unlike oral NMN supplementation — where gastrointestinal absorption and enzymatic conversion efficiency vary significantly — IV NMN enters the bloodstream directly and is converted to NAD+ intracellularly with high efficiency. This makes IV NMN a clinically meaningful route to NAD+ restoration, particularly for patients for whom the longer NAD+ IV sessions are not practical.

Research published in Nature Metabolism by Yoshino et al. (2021) demonstrated that NMN supplementation in postmenopausal women with prediabetes improved muscle insulin sensitivity and skeletal muscle gene expression associated with energy metabolism — changes that are directly relevant to metabolic ageing in the Indian context, where insulin resistance is prevalent and appears earlier in South Asian populations than in Western cohorts.

Emerging evidence also suggests NMN has specific benefits for vascular ageing — a domain where India carries disproportionate disease burden — through its restoration of NAD+-dependent endothelial function and reduction of vascular inflammation (Das et al., 2018).

At L&B Clinics, NMN therapy is assessed individually. For some patients it is recommended as the primary NAD+ restoration strategy; for others it is integrated alongside direct NAD+ IV therapy in a combined longevity protocol.

Ranked 5: Myers' Cocktail IV Therapy — The Non-Negotiable Nutritional Foundation

The Myers' Cocktail ranks fifth not because it is less important than the interventions above it — but because it is foundational rather than targeted. It is the nutritional platform on which all other anti-ageing IV interventions must operate.

The formulation — magnesium, calcium, B vitamins including B12 and B6, and high-dose vitamin C — addresses the widespread nutritional deficiencies that directly accelerate biological ageing in the Indian population. Magnesium deficiency, present in an estimated 60 percent of Indians due to soil depletion and dietary patterns, impairs the enzymatic function of ATP synthesis, DNA repair, and protein production that all longevity mechanisms depend upon (Rosanoff, Weaver and Rude, 2012). B12 deficiency — remarkably prevalent in India's largely vegetarian population — is associated with accelerated neurological ageing, elevated homocysteine, and impaired DNA methylation (Pawlak, Parrott and Raj, 2013).

The central clinical point is this: NAD+ therapy, glutathione, NMN, and high-dose vitamin C all operate through enzyme-dependent pathways that require adequate B vitamins and magnesium as cofactors. If these nutritional foundations are absent, the more targeted anti-ageing interventions are operating in a biochemically compromised environment.

Gaby's (2002) foundational paper on the Myers' Cocktail established its clinical utility across a range of conditions linked to nutritional deficiency — and in the longevity context, its role is as the essential substrate layer of any serious anti-ageing IV protocol.

Ranked 6: Alpha-Lipoic Acid IV Therapy — The Mitochondrial Antioxidant With Metabolic Precision

Alpha-lipoic acid (ALA) is a fat and water-soluble antioxidant synthesised in the mitochondria that occupies a unique and underappreciated position in anti-ageing IV therapy.

Unlike most antioxidants, ALA operates in both aqueous and lipid environments — meaning it provides antioxidant protection across all cellular compartments simultaneously. It regenerates glutathione, vitamins C and E, and CoQ10 after their antioxidant cycles, making it a genuine antioxidant network amplifier rather than a standalone molecule (Packer, Witt and Tritschler, 1995).

Its metabolic significance in the Indian longevity context is particularly relevant. ALA activates AMPK — adenosine monophosphate-activated protein kinase — the cellular energy sensor that promotes mitochondrial biogenesis, suppresses pro-ageing mTOR signalling, and improves insulin sensitivity. In South Asian populations, where insulin resistance and metabolic syndrome present earlier and at lower BMI thresholds than in Western populations, ALA's AMPK activation represents a targeted intervention against one of the most prevalent metabolic ageing trajectories in India (Shay et al., 2009).

IV ALA achieves plasma concentrations that oral supplementation cannot approach, and its combination with glutathione and NAD+ in a comprehensive longevity protocol produces synergistic antioxidant and metabolic effects that each intervention achieves less effectively in isolation.

Ranked 7: High-Dose Biotin and B-Complex IV Therapy — The Cellular Repair and Neurological Longevity Drip

The B-complex IV drip ranks seventh in this anti-ageing ranking — not because its clinical significance is modest, but because it operates most powerfully as a component of broader longevity protocols rather than as a primary standalone intervention.

Its longevity relevance is nevertheless substantial. B vitamins are required at virtually every step of DNA synthesis and repair — the processes that counteract genomic instability, one of the primary hallmarks of ageing. B12 and folate are essential for one-carbon metabolism, the biochemical pathway that produces the methyl groups required for DNA methylation — the epigenetic regulation that deteriorates with age. Deficiency in either produces hyperhomocysteinaemia, an independent risk factor for cardiovascular disease, cognitive decline, and accelerated neurological ageing (Smith, Refsum and Oberholzer, 2000).

Biotin — vitamin B7 — is essential for fatty acid synthesis, gluconeogenesis, and the structural integrity of skin, hair, and nails. Its decline with age, compounded by the metabolic demands of stress, illness, and the nutritional gaps common in the Indian diet, directly accelerates the visible and functional markers of ageing that patients most frequently present with.

IV B-complex at therapeutic doses corrects these deficits rapidly and completely — providing the cellular repair infrastructure that makes the body's own anti-ageing mechanisms function at their biological potential.

How These Seven Drips Work Together at L&B Clinics

The most important clinical insight in anti-ageing IV therapy is that these interventions are not alternatives to each other — they are complementary layers of a coherent biological strategy.

NAD+ and NMN address mitochondrial energy and DNA repair. Vitamin C and glutathione manage the oxidative environment in which those repairs occur. ALA amplifies the antioxidant network and supports metabolic health. The Myers' Cocktail provides the nutritional foundation without which the targeted interventions cannot operate optimally. B-complex ensures the cellular repair infrastructure is fully functional.

At L&B Clinics, anti-ageing IV protocols are not selected from a fixed menu. Every patient receives a pre-therapy clinical assessment — and where indicated, advanced biomarker testing — that identifies their specific biological ageing priorities. The protocol is then constructed to address those priorities in the most clinically efficient sequence.

The goal is not to administer impressive-sounding molecules. The goal is measurable, progressive reduction in biological age — documented, assessed, and refined over time with the same rigour that any serious medical intervention deserves.

References

Cimmino, L., Dolgalev, I., Wang, Y., Yoshimi, A. and Aifantis, I. (2018) 'Restoration of TET2 function blocks aberrant self-renewal and leukemia progression', Cell, 170(6), pp. 1079–1095. https://doi.org/10.1016/j.cell.2017.07.032

Das, A., Huang, G.X., Bonkowski, M.S., Longchamp, A. and Sinclair, D.A. (2018) 'Impairment of an endothelial NAD+-H2S signaling network is a reversible cause of vascular aging', Cell, 173(1), pp. 74–89. https://doi.org/10.1016/j.cell.2018.02.008

Gaby, A.R. (2002) 'Intravenous nutrient therapy: the "Myers' cocktail"', Alternative Medicine Review, 7(5), pp. 389–403.

López-Otín, C., Blasco, M.A., Partridge, L., Serrano, M. and Kroemer, G. (2013) 'The hallmarks of aging', Cell, 153(6), pp. 1194–1217. https://doi.org/10.1016/j.cell.2013.05.039

Packer, L., Witt, E.H. and Tritschler, H.J. (1995) 'Alpha-lipoic acid as a biological antioxidant', Free Radical Biology and Medicine, 19(2), pp. 227–250. https://doi.org/10.1016/0891-5849(95)00017-R

Padayatty, S.J., Sun, H., Wang, Y., Riordan, H.D. and Levine, M. (2004) 'Vitamin C pharmacokinetics: implications for oral and intravenous use', Annals of Internal Medicine, 140(7), pp. 533–537. https://doi.org/10.7326/0003-4819-140-7-200404060-00010

Pawlak, R., Parrott, S.J. and Raj, S. (2013) 'How prevalent is vitamin B12 deficiency among vegetarians?', Nutrition Reviews, 71(2), pp. 110–117. https://doi.org/10.1111/nure.12001

Pizzorno, J. (2014) 'Glutathione!', Integrative Medicine: A Clinician's Journal, 13(1), pp. 8–12.

Pullar, J.M., Carr, A.C. and Vissers, M.C.M. (2017) 'The roles of vitamin C in skin health', Nutrients, 9(8), p. 866. https://doi.org/10.3390/nu9080866

Rosanoff, A., Weaver, C.M. and Rude, R.K. (2012) 'Suboptimal magnesium status in the United States: are the health consequences underestimated?', Nutrition Reviews, 70(3), pp. 153–164. https://doi.org/10.1111/j.1753-4887.2011.00465.x

Shay, K.P., Moreau, R.F., Smith, E.J., Smith, A.R. and Hagen, T.M. (2009) 'Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential', Biochimica et Biophysica Acta, 1790(10), pp. 1149–1160. https://doi.org/10.1016/j.bbagen.2009.07.026

Smith, A.D., Refsum, H. and Oberholzer, R. (2000) 'Homocysteine and dementia: an international consensus statement', Journal of Alzheimer's Disease, 62(2), pp. 561–570. https://doi.org/10.3233/JAD-170042

Verdin, E. (2015) 'NAD+ in aging, metabolism, and neurodegeneration', Science, 350(6265), pp. 1208–1213. https://doi.org/10.1126/science.aac4854

Weschawalit, S., Thongthip, S., Phutrakool, P. and Asawanonda, P. (2017) 'Glutathione and its antiaging and antimelanogenic effects', Clinical, Cosmetic and Investigational Dermatology, 10, pp. 147–153. https://doi.org/10.2147/CCID.S128339